Gastritis is a widely spread inflammatory disease, mostly caused by Helicobacter pylori infection. Release of IL-8 by the stomach epithelium is a hallmark of gastritis and contributes to the amplification of the inflammatory state. Pharmacological modulation of IL-8 release is a strategy to relieve gastric inflammation and prevent more severe clinical outcomes. In search of nutraceuticals with potential anti-gastritis properties we used a bio-guided approach based on IL-8 secretion by gastric cells to characterize extracts from the fruits of different chestnut varieties.
Introduction
Gastritis is a very common inflammatory disease, mostly caused by Helicobacter pylori (H. pylori) infection [1] . This gram negative bacterium colonizes the gastric mucosa of over 80% of people in developing countries [2] and at least 50% of the world human population [3] . H. pylori infection induces a strong immune response in the host [4] , which is characterized by the release of several inflammatory cytokines in the gastric mucosa, including IL-8 and TNFα [5] [6] [7] [8] . Gastric epithelial cells exposed to cytokines, mostly TNFα and IL-1β, release IL-8, a potent chemokine, which promotes neutrophil infiltration [9] [10] [11] . IL-8 secretion is a typical hallmark in H. pylori-induced gastritis [12] , and its release by gastric epithelial cells is strictly associated with the activation of NF-κB [9, 13] , a transcription factor involved in a multitude of patho-physiological processes, including inflammation, cell growth, and proliferation [14] [15] [16] .
Plants rich in tannins have a traditional use for treating gastric ulcer; moreover, tannins showed anti-bacterial activity against H. pylori [17, 18] , and inhibition of gastric IL-8 release, both in vitro and in vivo [19, 20] . Epidemiological studies indicate that dietary consumption of proanthocyanidins (condensed tannins) has beneficial effects on a variety of chronic diseases, including metabolic syndrome, atherosclerosis, and cancer [21, 22] . Moreover, proanthocyanidins have been found unchanged after in vitro simulated gastric digestion [19] , and in vivo at gastric level [23, 24] , thus suggesting that the biological activity may occur in situ.
Chestnut tree (Castanea sativa Mill., sin. Castanea vesca Gaertn.) is a rich source of tannins, mostly in leaves, wood and bark, whereas fruits, which are a good source of essential dietary nutrients, showed lower levels of polyphenols [25] . In Italy, chestnuts from six geographical areas are regulated by Protected Geographic Indication (PGI) under European Union law and the average production of this fruit in the period 2003-2013 was close to 49,000 tons/year [26] . Despite high production of chestnut and the traditional dietary consumption in several European countries, only limited data on the tannin composition of fruits and their beneficial properties occur in the literature. Few studies performed on chestnut industrial by-products reported high content of phenols and marked antioxidant properties [27, 28] . Tannins were identified in fruits, although more precise details on their chemical features were not reported [29] [30] [31] .
The aim of this study was to characterize the anti-inflammatory properties of chestnut bioactive compounds, taking into consideration several variables (chestnut fruit parts, chestnut varieties, harvest year, chemical and thermal stability, etc). To this end we used a bio-guided approach based on IL-8 secretion by AGS cells stimulated with TNFα, a simple but validated model of gastritis induced by H. pylori.
Materials and methods

Materials
Dulbecco's Modified Eagle's Medium/F12 (DMEM)/F12 (1:1), penicillin, streptomycin, L-glutamine and trypsin-EDTA were from Gibco (Life Technologies Italia, Monza, Italy). Foetal bovine serum (FBS), and disposable materials for cell culture were purchased by Euroclone (Euro-clone S.p.A., Pero-Milan, Italy). Human adenocarcinoma cells (AGS, CRL-1739) were purchased from LGC Standard S.r.l., Milano, Italy.
The reagent 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and curcumin were from Sigma Aldrich (Milan, Italy). All reagents used for the biological assays were HPLC grade. Human TNFα and Human IL-8 Elisa Development Kit were from Peprotech Inc. (London, UK). All chromatographic solvents were HPLC grade or LC-MS grade for MS experiments. Acetonitrile, methanol, ethanol, formic acid, hydrochloric acid, vanillin, and iron sulfate were from Sigma Aldrich (Milan, Italy).
Plant material and preparation of the extracts
Chestnuts from five varieties (Venégon, Paié, Russirö, Verdésa and Piliscé) of Castanea sativa Mill. were collected by the farmer consortium in the regional area of Campo dei Fiori (Varese, Italy).
Fresh fruits were maintained under vacuum at 4°C until extraction. To obtain the extracts 2.5 g of milled whole fruit were extracted twice with 50 mL of water (aqueous extract) or ethanol/water 50:50 (hydroalcoholic extract) for 4 and 16 h, respectively, at room temperature under dark conditions. The mixture was filtered through Supervelox filter paper in order to remove plant debris; the extracts obtained were frozen with dry ice and alcohol and placed at −80°C overnight, then lyophilized and maintained at −20°C. In general, the yields of the aqueous and hydroalcoholic extracts of the same variety were comparable with the exception of Verdésa, whose hydroalcoholic yield was the half of the aqueous one.
Three parts of the fruits, endosperm (kernel) and the outer parts episperm (which directly covers the kernel) and pericarp (the woody part), were separated and extracted with hydroalcoholic solvent following the procedure previously described. The yield of the different parts varied according to the variety.
The yields (w/w) of each extraction were calculated as percentage of the dried extract weight in respect to the weight of the fresh starting material.
Commercially available flour, produced from the endosperm of dried chestnut (variety Venégon), and relative industrial by-product, constituted by episperm and pericarp, were extracted by hydroalcoholic solvent. Before proceeding with the biological evaluation, the extracts were dissolved in sterilized distilled water and DMSO (25%) at a concentration of 30 mg/mL, then stored in aliquots at −20°C. For the biochemical analysis, the lyophilized samples (10 mg) were dissolved in 5 mL of a mixture of methanol/water (2:1).
Cytotoxicity
The integrity of the cell morphology before and after treatment was assessed by light microscope inspection. Cell viability was measured, after 6 h treatment, by the 3,4,5-dimethylthiazol-2-yl-2-5-diphenyltetrazolium bromide (MTT) method. This method evaluates the activity of a mitochondrial enzyme, which is an index of cell viability.
Cell culture and IL-8 release measurement
AGS cells were grown at 37°C in DMEM F12 supplemented with 100 units penicillin per mL, 100 mg streptomycin per mL, 2 mM L-glutamine, and 10% heat-inactivated FBS (Euroclone S.p.A, Pero, Italy), under a humidified atmosphere containing 5% CO 2 .
Cells were grown in 24-well plates for 48 h (30 000 cells per well) before the cytokine treatment. The IL-8 secretion, induced by TNFα at 10 ng/mL, was tested after 6 h treatment in the presence of un-digested or digested extracts (0.1-100 μg/mL). Curcumin (10 μM) was used as the reference inhibitor of IL-8 secretion (80% inhibition). IL-8 was quantified using a Human Interleukin-8 ELISA Development Kit as described below. Briefly, Corning 96 well EIA/RIA plates from SigmaAldrich (Milan, Italy) were coated with the antibody provided in the ELISA Kit (Peprotech Inc., London, UK) overnight at 4°C. After blocking the reaction, 200 μl of samples in duplicate were transferred into wells at room temperature for 1 h. The amount of IL-8 in the samples was detected by spectroscopy (signal read: 450 nm, 0.1 s) by the use of biotinylated and streptavidin-HRP conjugate antibodies, evaluating the 3,3′,5,5′-tetramethylbenzidine (TMB) substrate reaction. Quantification of IL-8 was done using an optimized standard curve supplied with the ELISA Kit (8.0-1000.0 pg/mL).
NF-κB driven transcription
To evaluate the NF-κB driven transcription, AGS cells were plated in 24-well plates (30,000 cells per well). After 48 h, cells were transiently transfected by the calcium-phosphate method with the reporter plasmid (NF-κB-LUC, 50 ng/well) containing the luciferase gene under control of three κB responsive elements. The plasmid NF-κB-LUC was a gift of Dr. N. Marx (Department of Internal medicine-Cardiology, University of Ulm, Ulm, Germany). After 16 h, the cells were treated with the stimulus (TNFα 10 ng/mL) and the extract for 6 h. Curcumin (10 μM) was used as the reference inhibitor. At the end of this time, cells were harvested and the luciferase assay was performed using the Britelite ™ Plus reagent (PerkinElmer Inc., Walthman, MA, USA) according to the manufacturer's instructions. Data were expressed considering 100% of the luciferase activity related to the cytokine-induced promoter activity.
Total phenol content assay
Total polyphenol content was determined according to Folin-Ciocalteu's method, as reported by Singleton and Rossi [32] . Freeze-dried samples (50 mg) were solubilized in 1 mL of a 50:50 water:methanol solution. Aliquots of 300 μL from different samples were mixed in test tubes with 1.5 mL of Folin-Ciocalteu's reagent diluted 10 times, and 1.2 mL of 7.5% (w/v) sodium carbonate. After 30 min, the absorbance was measured at 765 nm in a UV-vis spectrophotometer (Varian Cary 50 SCAN, Palo Alto, CA, USA). The polyphenol content in samples was calculated using a standard curve of Gallic acid. Results were expressed as equivalents of Gallic acid in mg/g.
In vitro gastric digestion
According to a well-established protocol, the gastric digestion was simulated using an in vitro approach previously described [33] . Briefly, the extracts (100 mg) were incubated for 5 min at 37°C with 6 mL saliva juice, then 12 mL gastric juice were added to the suspension and the sample was incubated for 2 h at 37°C. At the end of the incubation, the digested sample was centrifuged for 5 min at 3000 g and the supernatant frozen and lyophilized. All the samples were then stored at −20°C until use for biological assays.
Evaluation of thermal stability
Heating treatment was performed directly on 10 mg of dried extracts, placed in pyrex vials, using a stove (Tecnovetro s.r.l., Monza, Italy) at different temperatures. The extracts were placed in the stove once the selected temperature was reached. The temperature was additionally controlled by a second thermometer during the incubation time. The heating treatment at 50°C reflected the temperature reached by the fruit during the industrial drying process, while 100°C was selected as boiling temperature, the same used for boiled chestnut preparation. After heating, 1-2 milligrams of the extract were weighted and solved in a mix of water and DMSO (3:1). The highest heating time (6 h) at 100°C led to carbonized insoluble particles, thus the extracts were centrifuged after the addition of the solvent to remove insoluble residues.
UPLC-MS/MS method for multiple classes of phenolics
Phenolic compounds were determined according to a previous method [34] . Briefly, an aliquot of the extract was filtered 0.22 μm in a HPLC vial. Chromatographic analysis was performed using a Waters Acquity UPLC system (Milford, USA) with a Waters Acquity HSS T3 column (100 mm x 2.1 mm; 1.8 μm). The flow was 0.4 mL/min and the gradient profile was 5% B for the initial condition; from 0 to 3 min linear gradient to 20% B; from 3 to 4.3 min, isocratic 20% B; from 4.3 to 9 linear gradient to 45% B; from 9 to 11 min, linear gradient to 100% B; from 11 to 13 min wash at 100% B and then from 13.01 to 15 min back to the initial conditions (B: acetonitrile containing 0.1% formic acid; A: water containing 0.1% formic acid). Mass spectrometry detection was performed on a Waters Xevo triple-quadrupole mass spectrometer detector (Milford, USA) with an electrospray (ESI) source [34] . A total of 24 polyphenols were identified among the samples and proper calibration curves were obtained for each individual compound for precise quantification.
Analysis of proanthocyanidins
The assay to determine the quantity of proanthocyanidins was based on their transformation into anthocyanidins, in a warm, acid environment [35] . 0.5 mL of the initial extract and 2.5 mL of MeOH were collected in a 50 mL flask, shielded from light with aluminum foil, containing 9.5 mL absolute EtOH. 12.5 mL of FeSO4 in concentrated HCl (300 mg/L) were added to the mixture and then immediately placed in a boiling water bath and refluxed for 50 min. After 10 min at room temperature, the spectrum from 380 to 700 nm was recorded in a 10 mm cell, against a blank (water). The tangent from the minimum (450 nm) was drawn, and the absorbance between the maximum (550 nm) and the tangent was measured. To subtract natural anthocyanins present in the sample, which can interfere with the assay, 0.5 mL of the extract was prepared under the same conditions, however, in this case the reaction was carried out in an ice bath and the absorbance obtained was then subtracted to obtain the net absorbance value. The proanthocyanidins concentration (mg/g) can conventionally be expressed as the cyanidin formed. Further information is available in the literature [35] [36] [37] .
Analysis of index of vanillin
The catechins and proanthocyanidins reactive to vanillin were analyzed according to the optimized and controlled vanillin-HCl method of Broadhurst and Jones [37, 38] , following the conditions described by Di Stefano et al. [39] . 0.5 mL of the initial extract and 0.5 mL of MeOH were collected in a 50 mL flask, shielded from light with aluminum foil, 6 mL of vanillin (4% in methanol) were added in the flask and 3 mL of HCl. To subtract the natural interference, 0.5 mL of the extract was prepared under the same conditions using 6 mL of pure methanol instead of vanillin solution. The absorbance was measured at 500 nm in a 10 mm cell, against a blank reaction. Concentrations were calculated as (+)-catechin (mg/g).
HPLC analysis of procyanidins
The PA subunit composition, percentage of galloylation (%G), percentage of prodelphinidins (%P), and mean degree of polymerisation (mDP), were determined after acid-catalysis in the presence of excess phloroglucinol (phloroglucinolysis) [40] . One hundred microliters of the sample were added to 900 μL of methanol and water (50/50 v/ v), filtered, and injected into the LC-MS system. One hundred microliters of sample were added to 100 μL of phloroglucinol reagent at 50°C for 30 min and then combined with 1 mL of sodium acetate to stop the reaction. The samples were filtered and immediately analysed.
Statistical analysis
All data are expressed as mean ± s.d.; data were analyzed by oneway analysis of variance (ANOVA) followed by Bonferroni as post-hoc test. Statistical analyses were done using GraphPad Prism 5.0 software (GraphPad Software Inc., San Diego, CA, USA). p < 0.05 was considered statistically significant. IC 50 was calculated using GraphPad Prism 5.00 software.
Results
Anti-inflammatory effects of chestnut extracts in human gastric epithelial (AGS) cells
The first step in the bio-guided approach used in the present study was the preparation of aqueous and hydroalcoholic extracts from freshly collected whole chestnut fruits from five varieties of Castanea sativa Mill. The yields of the extracts are reported in the supplementary materials (Table S1 ). None of the tested extracts displayed cytotoxic effects on AGS cells, evaluated by the MTT test (data not shown). We then assayed the potential anti-gastritis properties of chestnut fruit extracts (10 μg/ml) by measuring the amount of IL-8 released by AGS cells treated with TNFα for 6 h. As shown in Fig. 1 , only the extracts from Paié, Venégon, and Verdésa significantly prevented IL-8 release, and in all three cases the hydroalcoholic extracts exhibited higher inhibitory effect (Fig. 1, panel B vs panel A) .
The total phenol content in the extracts ranged between 7.80 and 96.67 mg, expressed as gallic acid equivalents (GAE)/g of extract. The highest content was found in Verdésa and Venégon extracts, both aqueous and hydroalcoholic, as shown in Fig. 1 , panel C. In general, the anti-inflammatory activity paralleled the total phenol content. Notably, in the case of Verdésa the use of the hydroalcoholic mixture was more efficient in extracting the phenolic fraction (96.67 vs 44.07 mg/g), thus suggesting a variety-specific composition of phenolic compounds exhibiting different physico-chemical properties.
The extracts from the most active varieties were further investigated in concentration-response experiments ranging from 0.5 to 100 μg/mL for the aqueous extracts ( Fig. 2A) and from 0.1 to 10 μg/mL for the hydroalcoholic extracts (Fig. 2B) .
All the aqueous and hydroalcoholic extracts inhibited the release of IL-8 in a concentration-dependent manner and, as expected, the hydroalcoholic extracts showed IC 50s between 2 and 11 times lower compared to the corresponding aqueous counterparts (Fig. 2C ). Based on these results, the hydroalcoholic extracts were selected for further investigations.
Since TNFα-induced expression of IL-8 depends on the NF-κB activation, we assayed the ability of hydroalcoholic extracts to modulate NF-κB driven transcription. AGS cells were transiently transfected with the NF-κB-luc reporter plasmid and treated for 6 h with the extracts at 10 μg/mL in the presence of TNFα (10 ng/mL). The inhibitory effects of the extracts were statistically significant only for the varieties Venégon and Verdésa. Furthermore, while the TNFα-induced release of IL-8 was completely prevented by 10 μg/mL Venégon and Verdésa hydroalcoholic extracts (Fig. 1B) , at the same concentration the NF-κB-driven transcription was inhibited only by 50-60%. Nevertheless, these results confirm that the NF-κB pathway is a key molecular target of chestnut bioactive compounds. Since in some cases, plant extracts, as single treatment, may induce an inflammatory response we evaluated the release of IL-8 and NF-κB-driven transcription in AGS cells treated with 10 μg/ml hydroalcoholic extract from the five chestnut varieties in the absence of TNFα. We found no change of IL-8 secretion nor of promoter activity upon 6 h treatment with the five extracts, thus excluding inflammatory effects in untreated cells (data not shown).
To get insights into the chemical entities contributing to the biological activity, we performed a detailed phytochemical characterization of the hydroalcoholic extracts from the five chestnut varieties, by UPLC-MS/MS. As reported in Table 1 , we identified different classes of compounds, including condensed tannins (e.g. proanthocyanidins), flavonoids (e.g. catechins), stilbenes (e.g. resveratrol), and phenolic acids (e.g. gallic and ellagic acids). The most active varieties (Paié, Venégon, Verdésa) contained significant levels (> 20 mg/g of extract) of high molecular weight proanthocyanidins, with a mean degree of polymerization (mDP) ranging between 3.2 (Venégon) to 6.7 (Piliscé). In contrast, these compounds were undetectable, in the least active variety, Russirò, thus suggesting that this class of molecules is a major contributor to the anti-inflammatory activity shown above. Considering the extraction efficiency, proanthocyanidins ranged from 0 to 1.75 mg/ g of the whole fruit (Table 1 , last bottom line).
In summary, we found that chestnuts contain bioactive compounds that inhibit the TNFα-induced secretion of IL-8 by gastric cells, by interfering, at least in part, with the NF-κB pathway. The content in bioactive compounds with anti-inflammatory properties varied among the five varieties and the hydroalcoholic mixture resulted the most efficient solvent to extract active molecules. The ability to inhibit IL-8 secretion correlated with the amount of proanthocyanidins in the tested extracts.
Contribution of the fruit parts to the biological activity
To investigate the contribution of the various parts of the fruit to the biological activity, hydroalcoholic extracts from the edible (endosperm) and not edible (pericarp and episperm) parts were prepared separately, as described in Section 2.2. In the biological assays, we tested the varieties that resulted more active, i.e. Paié, Venégon and Verdésa ( Figs. 1 and 2) .
The extracts obtained from endosperm, the edible part, were not active on IL-8 release till the maximum concentration tested (100 μg/ mL) (Fig. 4A) . On the contrary, the hydroalcoholic extracts from pericarp and episperm showed a concentration dependent inhibitory activity ( Fig. 4B and C, respectively) .
The two varieties active on NF-κB signaling, Venégon and Verdésa (Fig. 3) , were further investigated; the corresponding hydroalcoholic extracts, either from pericarp ( Fig. 5B) and episperm (Fig. 5C ), impaired the NF-κB driven transcription challenged by TNFα in a concentration dependent manner. The hydroalcoholic extracts from endosperm displayed no activity at any of the tested concentrations (Fig. 5A) .
The finding that none of the extracts from the edible part (endosperm) of the most active varieties displayed biological activity (Figs. 4A and 5 A) prompted us to investigate in more detail the phytochemical composition of the various extracts. As reported in Table 2 , high molecular weight proanthocyanidins, the putative bioactive fraction, were enriched (> 650 mg/g) in the extracts obtained from the episperm of Paiè, Venégon and Verdésa. The same applies to the extracts prepared from the pericarp, with concentration ranging from 145.1 mg/g (Paié) to 378.9 mg/g (Verdésa). The variety Verdesa resulted the richest source of high molecular weight proanthocyanidins, which accounted to about 90% of the episperm extract. Russirò, the variety exhibiting the lowest anti-inflammatory activity (Fig. 1B) , resulted almost devoid of proantocyanidins in any part. The anti-inflammatory activity resulted unrelated to the mean degree of polymerization (mDP) of proanthocyanydins. In fact, for example, the extracts from both pericarp and episperm of Venégon fruits displayed IC 50 of about 0.15 μg/mL (Fig. 4D) , while the mDP accounted to 8.2 and 2.9, respectively. The results shown above indicate that the biological activity is associated to the not edible parts of chestnut (pericarp and endosperm) in all the tested varieties. The phytochemical analysis confirmed that the hydroalcoholic extracts exhibiting the highest anti-inflammatory activity were richest in high molecular weight proanthocyanidins; the observation corroborates the hypothesis that these compounds confer to chestnut extracts the ability to prevent IL-8 secretion.
Effect of extrinsic variables on the biological activity of chestnut varieties
Chestnuts are widely used in food industry for sweets and flour production, through procedures that require heating. Therefore, we evaluated the anti-inflammatory property of hydroalcoholic extracts from Verdésa and Venégon chestnuts upon exposure to mild (50°C) and high (100°C) temperature, as described in Section 2.2. As shown in Fig. 6A , when heated at 50°C up to 6 h, both extracts maintained the inhibitory activity on IL-8 secretion. However, both extracts exhibited reduced activity upon exposure at 100°C in a time dependent manner; of note, the inhibitory effect was almost completely lost after 2 h of incubation at 100°C (Fig. 6B) .
The results shown so far refer to extracts prepared from fruits harvested in the year 2015. It is known that the quali-quantitative composition in bioactive compounds of medicinal and edible plants varies depending on multiple variables, including the harvest year; therefore, it is conceivable that the extent of the associated biological activities may vary as well. Given the low availability of fruits of the Verdésa variety, we focused on Venégon chestnuts. Hence, additional hydroalcoholic extracts from the whole fruit of Venégon were prepared from chestnuts collected in 2016 and 2017. The inhibitory activities (IC 50 s) exerted by Venégon (2015) and Venégon (2016) were comparable, while the extract of Venégon (2017) was less effective (Fig. 7A) . Although we did observe different degree of activity depending on the harvest year, most likely due to the amount of bioactive proanthocyanidins, the calculated IC 50s were in all cases below 10 μg/mL (Fig. 6B) .
A critical issue in nutraceuticals and botanicals is their fate in the gastro-intestinal tract, including chemical stability and absorption, which affect the biological activities. Chemical stability in the stomach environment is certainly highly relevant for extracts and compounds acting directly on gastric cells. To this end we investigated whether the prevention of IL-8 secretion could be maintained under the acidic conditions of the stomach and the action of digestive enzymes. The hydroalcoholic extract of the whole fruit of the Venégon variety (harvest year 2015) was subjected to in vitro simulated gastric digestion, as described in Section 2.7. The simulated digestion only slightly affected the biological activity of the extract (Fig. 8A) , increasing the IC 50 from 1.50 ± 0.52 to 4.13 ± 1.83 μg/mL ( ± s.d.), as reported in Fig. 8B .
The results shown above indicate that, taking into account critical variables (thermal treatment, harvest year, gastric digestive environment), Venégon chestnut resulted a valuable source of bioactive compounds with potential anti-inflammatory activities at the gastric level.
Biological activity of industrial chestnut flour and related by-product
To verify the practical application of our results, we investigated the biological activity of hydroalcoholic extracts from finished products (flour) and by-product obtained by industrial processing of Venégon chestnuts (harvest year 2015). The extract prepared from by-product, consisting of the not edible parts (pericarp and episperm) and resulting from mechanical peeling, displayed inhibitory activity on IL-8 secretion (Fig. 9A ), in line with the results shown in Fig. 4B and C ; the calculated IC 50 was 0.20 ± 0.04 μg/mL ( ± s.d.), highly similar to that reported in Fig. 4D . These results indicate that the mechanical peeling procedure does not alter the potential biological activity of the not edible chestnut parts. The in vitro gastric digestion did not affect the biological activity of the extract, as shown in Fig. 9B , which still exhibited an IC 50 of 0.15 ± 0.02 μg/mL ( ± s.d.), consistent with the findings reported in Fig. 8A . On the contrary, the extract prepared from industrial flour, mainly constituted of endosperm, showed absence of activity (Fig. 9C) , confirming the results reported in Fig. 4A . Thus, our data suggest that chestnut-based products prepared exclusively from endosperm lack anti-inflammatory activity, while industrial by-product may represent a valuable source of bioactive material. In the view of improving the nutraceutical properties of chestnut flour, we prepared a hydroalcoholic extract starting from a mixture of flour and episperm, maintaining the ratio found in the fruits (22:3, for endosperm and episperm, respectively). We used flour, and episperm from Venégon fruits harvested in 2015. The extract prepared from flour enriched with episperm (final concentration 12%, w:w) showed inhibitory activity with an IC 50 of 16.35 ± 5.22 μg/mL ( ± s.d.), as shown in Fig. 9D .
In conclusion, we demonstrated that chestnut flour is devoid of any anti-inflammatory activity while industrial by-product retains the ability to inhibit IL-8 secretion. These findings provide experimental evidence in support of the potential use of chestnut-derived material for the preparation of nutraceuticals and functional foods, e.g. "fortified" flour. 
Discussion
Castanea sativa Mill. is a rich source of polyphenols due to its high tannin content, and its fruits are widely used in food industry for sweets and flour production [61] . Nevertheless, a detailed phytochemical profile of chestnut fruits, in relation to their biological activities, has not been investigated in depth.
By means of a validated bio-guided approach, coupled to a thorough phytochemical analysis, we were able to isolate the bioactive fraction of chestnut fruits exhibiting anti-inflammatory activity in gastric cells. This approach was instrumental for the selection of the most appropriate extraction system (hydroalcoholic mixture vs water), thus resulting more informative than the simple measurement of the phenolic content.
Proanthocyanidins represent an emerging class of anti-inflammatory compounds and our study further supports their pharmacological potential in the field of gastric inflammation. The detailed phytochemical characterization of various chestnut varieties and fruit parts, coupled to the robust biological assay, allowed us to assign the anti-inflammatory activity to this class of compounds, to identify the most active varieties and the contribution of the fruit parts. Thus, chestnut fruit, especially the inner and outer skins, can be included in the list of natural sources of proanthocyanidins. Moreover, the amount of proanthocyanidins could represent an index to titrate tannin enriched nutraceuticals.
Although our data clearly show that the edible part of chestnut fruits was not active, the by-product resulted highly enriched in proanthocyanidins and, consequently, with significant anti-inflammatory activity (IC 50 < 1 μg/ml). These findings contribute to assessing the health beneficial value of chestnut-based foods and nutraceuticals, and to the potential valorization of chestnut processing wastes.
Another outcome of our study is the valorization of Castanea sativa Mill. varieties that combine appreciated organoleptic properties with high nutraceutical value, such as the Venégon and Verdésa varieties. Future efforts should be aimed at promoting preservation and cultivation of these varieties, optimizing the use and manipulation of byproduct, with the aim to develop chestnut-based nutraceuticals and functional foods, with no negative effects on their palatability and taste. These aspects will be investigated in the near future. Our study also provides hints that may result useful for optimizing the processing of chestnut-based products and the treatment of wastes. Elevated temperatures (> 100°C) are often used to facilitate the peeling procedure, to prepare chestnut-based foods (e.g. cakes, pasta, etc.), or to increase the extraction efficiency in preparing chestnut-derived ingredients. Our data demonstrate that prolonged exposure (> 1 h) at 100°C leads to complete loss of anti-inflammatory activity while upon treatment at 50°C the biological activity is fully preserved.
Key steps that may influence the biological activities associated to nutraceuticals are their chemical modifications that may occur during the digestive process and the absorption rate by the gastro-intestinal tract. In the case of gastric inflammation, absorption may be less relevant since bioactive compounds can act directly on gastric cells, but resistance to acid environment and enzymes is a crucial issue. By using an in vitro simulated digestion system, we could demonstrate that chestnut extracts maintain the ability to prevent IL-8 secretion, thus providing evidence in support of their potential use in vivo. Moreover, taking into consideration the amount of proanthocyanidins that could be added to chestnut-based foods (e.g. flour, flakes, etc.), the calculated IC 50 reported in the present study, the approximate gastric volume (30-40 mL), it is conceivable that concentrations sufficient to obtain anti-inflammatory effects could be easily reached in vivo.
Conclusion
Overall, by combining a robust bio-guided approach with a comprehensive analysis of the tannic fraction of chestnut extracts, we provided evidence for the potential use of chestnut-based nutraceuticals in human gastritis. The bioactive components of chestnut fruits inhibit IL-8 secretion most likely by means of multiple mechanisms, including impairment of NF-κB signaling, thus confirming the importance of this pathway as a general target in the field of anti-inflammatory agents; on the other hand, the discovery of additional targets would open new applications for inflammation-based diseases.
The finding that the anti-inflammatory activity is maintained upon treatment in acidic conditions and with digestive enzymes, further corroborates the applicability of our observations in human gastritis. Finally, our study also offers hints useful for the valorization of specific chestnut varieties and for setting up the most appropriate conditions for the preparation of chestnut-based nutraceuticals with intact biological activities. 
